Defining the Molecular Point of Care (mPOC) Market in 2024

Defining the molecular point of care (mPOC) market is the first step in market-sizing this segment. The mPOC market refers to the use of molecular diagnostic tests at or near the patient’s location to enable rapid and actionable clinical decisions. These tests typically involve the detection of nucleic acids (DNA or RNA) from pathogens or […]

Cancer, Obesity, Diabetes, and Cardiovascular Disease Drive South Korea’s IVD Investment

South Korea ranks as the fifth largest health market in the Asia Pacific region, following China, Japan, Australia, and India.. South Korea’s investment in healthcare, medical devices, and diagnostics is driven by the burden of obesity, diabetes, cardiovascular disease, and cancer. The country’s business environment for medical devices and equipment is favorable and streamlined for […]

Non-COVID-19 Vaccines Get Post-Pandemic Boost

Infectious diseases are some of the deadliest diseases that pose a significant risk to human life. Since the advent of the pandemic, scientists worldwide have intensified research and development of preventative vaccines that will hopefully combat existing and new infectious disease threats. Because of this dedicated focus, the global market for human preventive vaccines experienced […]

Medical Devices: A Clearer Look at X-Ray Imaging

The evolving healthcare landscape, influenced by factors such as expanded health insurance coverage from the Affordable Care Act, rising acute and chronic illness rates, and modernization of healthcare facilities, is driving growth in medical imaging products. While cost containment efforts may impact pricing, tests improving therapeutic outcomes are expected to thrive. In Kalorama Information’s report […]

Liquid Biopsy on Frontlines as Prostate Cancer Concerns Escalate

Each year, tens of thousands of men succumb to prostate cancer, a disease with an almost 100% survival rate when diagnosed early. According to a recent article by Fortune, rates of prostate cancer, America’s second-deadliest cancer in men, are on the rise. Since 2014, the U.S. has seen a 3% annual increase in diagnoses of […]

What’s Driving and Restricting Out-of-Pocket Healthcare Spending in the U.S.

Over the next five years, projections indicate a continued increase in total consumer out-of-pocket expenditures for healthcare, maintaining the upward trajectory observed in recent years. Despite a temporary slowdown during the COVID-19 pandemic of 2020 and 2021, the historical trend resumed in 2022 and persisted through 2023, with expectations for ongoing growth. These insights stem […]

Veterinary Diagnostics: IDEXX, Mars Petcare, and Zoetis Driving 7% CAGR 2023-2028

In recent years, there has been a noticeable increase in diagnostic testing within animal healthcare, attributed to a surge in pet ownership and the emergence of various zoonotic diseases. Diagnostic testing plays a crucial role in animal healthcare, offering veterinarians a diverse range of tests for disease identification and monitoring. The efficacy of diagnostic testing […]

Teletherapy Gains Momentum in U.S. Schools Amid Rising Mental Health Challenges

Telemedicine to address the growing need for mental health monitoring and intervention is one of several market opportunities that offer intriguing benefits over traditional office-based care. Also known as teletherapy (as well as telemental health, telehealth therapy, or telepsychiatry), this specific form of telemedicine is an area where interest has increased significantly, as barriers to […]

Liquid Biopsy: Double-Digit Growth in Increasingly Competitive Global Market

In 2023, global liquid biopsy market sales exceeded $1 billion. Projections indicate a substantial growth trajectory, with an anticipated average annual double-digit growth rate over the next several years. By 2028, the market’s growth will reflect significant momentum and rapid expansion during the forecast period. This is according to The Worldwide Market for Liquid Biopsy, […]

Molecular HPV Testing: 6.6% Revenue Growth 2023-2028

January is Cervical Health Awareness Month, a reminder that more than 95% of cervical cancer cases are attributed to the human papillomavirus (HPV), according to the World Health Organization (WHO). HPV testing is a key segment of the double-digit, multi-billion-dollar global molecular diagnostic testing market, according to the new report The World Market for Molecular […]